PHF14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.201600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.905400E-01
Normal-vs-Stage2
8.587600E-01
Normal-vs-Stage3
1.164430E-01
Normal-vs-Stage4
7.011800E-01
Stage1-vs-Stage2
5.299200E-01
Stage1-vs-Stage3
2.439700E-02
Stage1-vs-Stage4
8.012200E-01
Stage2-vs-Stage3
8.926400E-02
Stage2-vs-Stage4
4.358400E-01
Stage3-vs-Stage4
1.162830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.698800E-01
Normal-vs-AfricanAmerican
9.600800E-01
Normal-vs-Asian
9.118400E-01
Caucasian-vs-AfricanAmerican
7.220200E-01
Caucasian-vs-Asian
7.836000E-01
AfricanAmerican-vs-Asian
9.128400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.526200E-01
Normal-vs-Female
7.791000E-01
Male-vs-Female
7.104200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.470800E-01
Normal-vs-Age(41-60Yrs)
9.870600E-01
Normal-vs-Age(61-80Yrs)
7.010800E-01
Normal-vs-Age(81-100Yrs)
9.286800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.672000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.635600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.730400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.463010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.877400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.811400E-01
Normal-vs-Daily Drinker
4.522200E-01
Normal-vs-Weekly Drinker
7.867200E-01
Normal-vs-Occasional Drinker
9.705400E-01
Normal-vs-Social Drinker
8.660600E-01
Non Drinker-vs-Daily Drinker
4.313200E-01
Non Drinker-vs-Weekly Drinker
8.046000E-01
Non Drinker-vs-Occasional Drinker
4.453200E-01
Non Drinker-vs-Social Drinker
2.880800E-01
Daily Drinker-vs-Weekly Drinker
3.821400E-01
Daily Drinker-vs-Occasional Drinker
1.585440E-01
Daily Drinker-vs-Social Drinker
1.231170E-01
Weekly Drinker-vs-Occasional Drinker
6.747000E-01
Weekly Drinker-vs-Social Drinker
4.940200E-01
Occasional Drinker-vs-Social Drinker
6.944800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.159400E-01
Normal-vs-Grade 2
7.458400E-01
Normal-vs-Grade 3
6.620200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.183400E-01
Grade 1-vs-Grade 3
3.871700E-02
Grade 1-vs-Grade 4
8.159400E-01
Grade 2-vs-Grade 3
9.616200E-02
Grade 2-vs-Grade 4
7.458400E-01
Grade 3-vs-Grade 4
6.620200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.771200E-01
Normal-vs-NonDiabetic
8.581800E-01
Diabetic-vs-NonDiabetic
1.484840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.686400E-01
Normal-vs-NoPancreatitis
8.025400E-01
Pancreatitis-vs-NoPancreatitis
9.792000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.942400E-01
Normal-vs-N1
9.000000E-01
N0-vs-N1
4.956600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.108600E-01
Normal-vs-TP53-NonMutant
9.354800E-01
TP53-Mutant-vs-TP53-NonMutant
7.770300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
